Home Cart Sign in  
Chemical Structure| 1629138-41-5 Chemical Structure| 1629138-41-5

Structure of SRI-011381
CAS No.: 1629138-41-5

Chemical Structure| 1629138-41-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SRI-011381 is an agonist of TGF-beta signaling pathway, can be used in the treatment of Alzheimer’s disease.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SRI-011381

CAS No. :1629138-41-5
Formula : C20H31N3O
M.W : 329.48
SMILES Code : O=C(NC1CCCCC1)N(CC2=CC=CC=C2)CC3CCNCC3
MDL No. :MFCD01475985
InChI Key :LNOPAJNGRAPFKZ-UHFFFAOYSA-N
Pubchem ID :77050694

Safety of SRI-011381

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
mouse fibroblasts 10 μM 12 hours SRI-011381 eliminated the protective effects of SSA on fibroblasts PMC6231222
EndoC-βH1 cells 100 µM 16-18 hours To evaluate the effect of SRI-011381 on HLA-I expression, results showed that SRI-011381 treatment reduced HLA-I expression. PMC11814175
K562 cells 460 μM 24 hours CRISPRi screen to identify the target of C381, results suggest that C381 may act by targeting the lysosome. PMC8931323

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Experimental Autoimmune Encephalomyelitis (EAE) model Intraperitoneal injection 50 μM, 200 μM, 1 mM 2 hours SRI-011381 partially rescued the deficits in the optic nerve and retina of YAPGFAP-CKO EAE mice, reducing inflammatory infiltration and demyelination PMC8344002
Mice APAP-induced acute liver injury model Intraperitoneal injection 0.5 - 3 million WT CD4+ cells Single injection, observed for 3 weeks SRI-011381 significantly reversed the inhibitory effect of SIN on the TGF-β/Smad pathway and reversed the protective effect of SIN against APAP-induced acute liver injury. PMC7306499
Mice Progranulin 2/2 mice and MPTP mouse model Intraperitoneal injection 1 hour In two neurodegenerative disease models, C381 exhibited potent anti-inflammatory and neuroprotective effects, particularly in the PD model, where C381 restored cognitive function and rescued dopaminergic neuron loss. PMC8931323

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.04mL

0.61mL

0.30mL

15.18mL

3.04mL

1.52mL

30.35mL

6.07mL

3.04mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories